Stock Analysts

Upcoming Oil Earnings to Watch: DO, USAC, GPOR

We have crossed the half-way mark of the Q4 earnings season, with 322 S&P 500 members having reported their numbers. This accounts for 78.1% of the index’s total market capitalization. Per the latest Earnings Trends , total earnings for these companies are up 15.3% from the same period last year on 9.4% higher revenues, with 79.6% companies delivering positive earnings surprises and 76.9% beating revenue estimates […]

Stock Analysts

Glaxo’s (GSK) Begins Phase III HIV Two-Drug Regimen Study

GlaxoSmithKline GSK along with partner Pfizer, Inc. PFE announced that their HIV-focused joint venture company, ViiV Healthcare, has initiated a phase III program to evaluate its two-drug HIV regimen of dolutegravir (Tivicay) and lamivudine (Epivir) The study will evaluate the two-drug regimen for maintenance of viral suppression achieved in HIV-1 infected patients on a three-drug regimen – tenofovir alafenamide fumarate ("TAF")-based regimen. […]

Stock Analysts

United Continental January Traffic Up, Load Factor Down

United Continental Holdings, Inc .’s UAL wholly owned subsidiary, United Airlines, reported unimpressive traffic numbers for January, with load factor (percentage of seats occupied by passengers) declining owing to capacity overexpansion. Traffic, measured in revenue passenger miles (RPMs), was 16.33 billion, up 1.8% from the year-ago figure. O n a year-over-year basis, consolidated capacity (or available seat miles/ASMs) also gained 3.3% to 20.62 billion. […]

Stock Analysts

PG&E Corp (PCG) Earnings Trail Estimates in Q4, Decline Y/Y

PG&E Corporation ’s PCG adjusted operating earnings per share of 63 cents in fourth-quarter 2017 missed the Zacks Consensus Estimate of 69 cents by 8.7%. Earnings were also down 52.6% from $1.33 reported in the year-ago quarter. The downside in adjusted earnings was caused by the timing of the 2015 GT&S rate case, which delayed recognition of the full 2016 revenue increase until the fourth quarter of 2016 […]